Valeant withdrew its unsolicited offer to acquire ophthalmic company Ista for $7.50 per share in cash, or about $377M

Ista Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$277.2m on 12/16/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Valeant Pharmaceuticals International Inc.

Canada / Mid-Cap Biopharma ($1-$50 billion)

$13,721.5m on 12/16/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled